3rd Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$650,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network. Discuss the issue of surprise medical bills with Congressional staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with Congressional staff. Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with Congressional staff. Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with Congressional staff. Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch. Discuss 405(d) Educational Programming with the HHS Office of Chief Information Officer. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); President of the U.S.; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Emergency Management Agency (FEMA); White House Office

Bills named: S. 384 (116th), H.R. 3414 (116th), H.R. 3630 (116th), H.R. 3 (116th), S. 2543 (116th), S. 1895 (116th), S. 116 (116th), H.R. 3502 (116th), H.R. 1763 (116th)

Budget/Appropriations BUD

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: Health & Human Services, Dept of (HHS); White House Office; Federal Emergency Management Agency (FEMA); HOUSE OF REPRESENTATIVES; SENATE; President of the U.S.; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA)

Pharmacy PHA

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss potential legislation to address drug shortages with Congressional staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
AISLING WARDE ZACCARELLI —
SETH DEAN WARSHAW —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); President of the U.S.; Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Federal Emergency Management Agency (FEMA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 965 (116th), H.R. 938 (116th), H.R. 1499 (116th), H.R. 3 (116th), H.R. 1503 (116th), H.R. 1506 (116th), S. 340 (116th), H.R. 2296 (116th), H.R. 985 (116th), S. 2543 (116th), H.R. 1520 (116th)

Taxation/Internal Revenue Code TAX

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); White House Office; Federal Emergency Management Agency (FEMA); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); President of the U.S.; Substance Abuse & Mental Health Services Administration (SAMHSA)

Medicare/Medicaid MMM

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Educate Congressional staff and lawmakers on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KAREN SMOLER HELLER —
TIM JOHNSON —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —
ELISABETH R WYNN —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Federal Emergency Management Agency (FEMA); Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); President of the U.S.; Executive Office of the President (EOP); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); White House Office; Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 1763 (116th), S. 384 (116th), S. 2543 (116th), H.R. 3414 (116th)

Affiliated organisations

OrganisationLocation
ACURITY, INC. New York, NY, US
GNYHA MANAGEMENT CORPORATION New York, NY, US
GNYHA VENTURES, INC. New York, NY, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.